Myxomatosis in Australia and Europe: a model for emerging infectious diseases
about
Host-Pathogen Coevolution: The Selective Advantage of Bacillus thuringiensis Virulence and Its Cry Toxin GenesTherapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic StrategiesThe origin of the variola virusThe evolution and genetics of virus host shiftsThe α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppressionComparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptationsPrediction of steps in the evolution of variola virus host rangePoxviruses and the evolution of host range and virulenceNematode endoparasites do not codiversify with their stick insect hostsEarly infections by myxoma virus of young rabbits (Oryctolagus cuniculus) protected by maternal antibodies activate their immune system and enhance herd immunity in wild populations.Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3Imperfect Vaccination Can Enhance the Transmission of Highly Virulent PathogensA whole-genome RNA interference screen for human cell factors affecting myxoma virus replicationDistribution and prevalence of the Australian non-pathogenic rabbit calicivirus is correlated with rainfall and temperatureInsights into the European rabbit (Oryctolagus cuniculus) innate immune system: genetic diversity of the toll-like receptor 3 (TLR3) in wild populations and domestic breedsGene delivery of a viral anti-inflammatory protein to combat ocular inflammationTiming and severity of immunizing diseases in rabbits is controlled by seasonal matching of host and pathogen dynamicsViral biocontrol: grand experiments in disease emergence and evolution.Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.Oncolytic Poxviruses.Theory and empiricism in virulence evolutionThe causes and consequences of changes in virulence following pathogen host shifts.Exploring Host-Pathogen Interactions through Biological Control.Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cellsAn overview of the lagomorph immune system and its genetic diversity.Rabbit biocontrol and landscape-scale recovery of threatened desert mammals.Assessing the contribution of interferon antagonism to the virulence of West African Ebola virusesMolecular epidemiology of Rabbit Haemorrhagic Disease Virus in Australia: when one became many.Increased virulence of rabbit haemorrhagic disease virus associated with genetic resistance in wild Australian rabbits (Oryctolagus cuniculus)Genomic and phenotypic characterization of myxoma virus from Great Britain reveals multiple evolutionary pathways distinct from those in Australia.A cross-species view on virusesWhat Can Phages Tell Us about Host-Pathogen Coevolution?Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasisMyxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolatesLaGomiCs-Lagomorph Genomics Consortium: An International Collaborative Effort for Sequencing the Genomes of an Entire Mammalian OrderAmphibians with infectious disease increase their reproductive effort: evidence for the terminal investment hypothesisOncolytic myxoma virus: the path to clinicIncreasing virulence, but not infectivity, associated with serially emergent virus strains of a fish rhabdovirus.Genome scale evolution of myxoma virus reveals host-pathogen adaptation and rapid geographic spread.Immune responses of wild birds to emerging infectious diseases.
P2860
Q21145699-F2BBA18A-B100-48D8-9143-9DAD715C8A31Q26751959-2BB1087A-98AD-484A-A93F-52E7E3201B61Q26863252-82D7A7BD-D731-46AE-85EC-D9333000AD46Q27004307-766B8C80-2C12-4BD9-A092-1259959AA944Q27312735-9E602529-A670-49A4-9E3D-D41C8EA74F8BQ28390207-F73C4D53-A31E-415B-8E6D-5FCD33476DC0Q28657815-703A3035-38F9-46C1-B9C9-6DBE29ED7AA5Q28658130-A1BF939A-C5DB-4EF9-B8F1-84A8986E827BQ28830320-54856B1A-C12E-40AD-957A-616F806C901CQ33585153-D67AF589-A704-46FF-9C64-28E953459A8EQ33690901-8C920865-21CE-46C6-89D6-0ABA0B89D5EAQ34044564-7AB8F739-A2FC-4B45-8C0B-977E0F586D17Q34585582-BB5F9437-4033-4B5A-A823-28AA663D1306Q34653564-DF41C0AD-CCB0-412C-A97E-99F27535A24BQ34960335-2EFE669F-ADB1-4B91-99F8-B21EB550080DQ35000601-AE9AEB97-DEC9-484E-8742-9327CE110B9AQ35009380-53B617DC-6E11-4E93-86CE-336646F23737Q35070496-674AA3C5-9FC0-44A5-909C-FDBF996D9A18Q35232793-520E3BD2-096D-4F73-A724-D1F1C4C95A63Q35234349-F11A5263-090F-4392-AD73-EBCDE0EBBE3AQ35362151-E8F1031F-A332-4C8D-99C3-EC06946E4036Q35578096-063B4BFD-0314-4D6B-9BB3-4569C88187B5Q35673864-DA6DC4CC-DB8A-41F9-A103-C74CB3DBD80FQ35724025-3D439E6B-6007-4EDA-9698-53699CB8ABF7Q35785529-E78E4163-01F1-4709-B4B2-F0C28E200FD0Q35916803-12F06FE8-2FCF-410E-B2B5-68FB0033A370Q35922893-1EED8BA7-21B7-469D-818D-8DD2104D09E6Q36126624-F51DA746-9551-4BF5-9051-A70C25FB3AF9Q36138748-AD0EBFD7-7D0F-4A6E-9EA4-4658F2978E8FQ36295619-37B00804-CCA9-492E-9ED3-ADD4BA216901Q36315441-DE0A9EC2-71FB-4F40-88A7-3C8907F8ABB2Q36424693-8965B07A-32D0-446C-A499-B46E49D2A295Q36664249-74569CFC-B044-449D-9BD9-20F973A4B8D7Q36802323-374660F8-9FD3-4887-96AB-4E6DFB71AC44Q36954998-56CB9556-1901-4873-8B53-F72BD19FB842Q37058133-1C117482-7B66-4BC3-9BEA-50C1889A252AQ37126088-BC052B23-9438-4CB2-91E0-0ECBD461D9FBQ37186657-1B1ABE01-0CDE-4A7F-B1FA-F517CFFB4A7EQ37336515-5E02C3A6-3951-49BC-9FCA-4549C6DA7BFAQ38408340-0391FD52-2A12-4166-A6DB-96A3C14FB9D6
P2860
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
@ast
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
@en
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
@nl
type
label
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
@ast
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
@en
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
@nl
prefLabel
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
@ast
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
@en
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
@nl
P3181
P1433
P1476
Myxomatosis in Australia and Europe: a model for emerging infectious diseases
@en
P2093
Peter J Kerr
P304
P3181
P356
10.1016/J.ANTIVIRAL.2012.01.009
P407
P577
2012-03-01T00:00:00Z